Companies

See how salaries can vary from company to company

Truveris provides a pharmacy pricing and benefits analysis platform that offers prescription drug ecosystem services to the health care industry. view company details

BridgePhase provides information technology and enterprise software consulting services. view company details

Chartis Federal is a provider of engineering, management and Information Technology consulting services. view company details

City of Anaheim is a Municipal government organization that provides information about Anaheim. view company details

City of Olathe provides city information, news and event details. view company details

Datawiz provides building, securing and managing Information Technology infrastructures. view company details

Lurn is a provider of online education and information solutions for the marketing professionals. view company details

Quadrint offers Information Technology consulting, staffing and application development services. view company details

SSP provides geographic information systems implementation, customization and integration services. view company details

WTCC offers an information on degrees, courses and admission procedures. view company details

WebMD is an online platform that publishes healthcare and medical news and information. view company details

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). Its lead product candidate is TRC105, an endoglin antibody, which is in randomized Phase III clinical trial for angiosarcoma; Phase I/II clinical trial for hepatocellular carcinoma; Phase I clinical trial for lung cancer; Phase I/II clinical trial for breast cancer; Phase II clinical trials for prostate cancer; and randomized Phase II clinical trial for wet AMD. The company also develops TRC102, a small molecule t... view company details

As a people-centric digital marketing company, our primary goal is to connect small business owners across the country with their target audiences. We do that by building comprehensive online presences designed to get business owners found online, attract customers and grow their businesses. Our people are passionate about helping business owners succeed, and they know the value of dedication and expertise. That's why our clients never have to wait in online help queues for support. They work with one digital marketing specialist throughout their campaigns, and they always have their specialis... view company details

We are Future. A global specialist multi-media platform that creates loyal communities across a portfolio of over 200 compelling brands. Every month we engage with over 400 million people globally through websites, events and magazines, with our content reaching 1 in 3 adults online in both UK & the US. Founded in 1985, we have grown significantly to a global business over over 2,000 colleagues. We are the largest magazine publisher in the UK with a combined circulation of more than 3 million across our publications. We haven't just survived in 2020, we've thrived, increasing our audience shar... view company details

Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers. It offers protection against termite damage, rodents, and insects to homes and businesses, including hotels, food service establishments, food manufacturers, retailers, and transportation companies. The company also provides pest management and sanitation services and products to the food and commodity industries; consulting services on border protection related to Australia's biosecurity program; and bird control and specialist services, as well as offers specialized se... view company details

Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases primarily in the United States. The company's lead products candidate is tazemetostat, an inhibitor of the EZH2 histone methyltransferase, which is in the Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL); Phase II clinical trial for relapsed or refractory patients with mesothelioma characterized by BAP1 loss-of-function; and Phase II clinical trial for adults and Phase I clinical trial fo... view company details

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which i... view company details

CTD Holdings, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. CTD Holdings, Inc. was founded in 1990 and is based in Gainesville, Florida. view company details

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trials for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase ... view company details

CytRx Corporation, a biopharmaceutical company, engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and Aldoxorubicin, a conjugate of prescribed chemotherapeutic agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of the tumor. It also provides albumin companion diagno... view company details